support

Informed Insights: Prior Authorization Study

Original research and analysis from InformedDNA “Access to Genetics Experts Improves Outcomes of Genetic Testing Prior Authorizations” As the nation’s largest independent organization of genetics specialists, InformedDNA leverages the expertise of our staff and their work with thousands of patients per month and clients representing nearly 100 million lives to offer original research and analysis …

Informed Insights: Prior Authorization Study Read More »

Informed Insights: Pre-Test Genetic Counseling

Original research and analysis from InformedDNA Pre-Test Genetic Counseling Requirement Benefits Health Plans and Patients The application of complex genetics in healthcare often requires specialized knowledge and training. Many providers report discomfort with selecting, interpreting and managing genetic tests and results. In healthcare, a team approach benefits patients. And, genetic counselors are valuable team members …

Informed Insights: Pre-Test Genetic Counseling Read More »

Informed Insights: Coverage Decision FrameworkTM

Original research and analysis from InformedDNA “An Inventive Approach to Genetic Test Policy Development for Health Plans” Rapid advances in genomic science and precision medicine require new approaches to health plan policy and evidence review processes. Using incomplete and outdated approaches to medical policy for complex genetic tests puts health plans at risk of lagging …

Informed Insights: Coverage Decision FrameworkTM Read More »

Using Genomics Expertise to Take Personalized Therapeutics from Clinical Trials to Market

The impact of genomics on the development of personalized medicine is only accelerating. Today, according to the American Society of Human Genetics (ASHG), nearly half of all NIH-funded research has a genomics component. In addition, more than 7,000 rare diseases exist, with fewer than 500 FDA-approved treatments at this time. Given that 80% of rare diseases …

Using Genomics Expertise to Take Personalized Therapeutics from Clinical Trials to Market Read More »

Case Study: Genetic Test Payment Integrity

Payment Integrity Edits Identify $26.5M in Inappropriate Genetic Testing Payments Driven by the rapid and ongoing increase in the number of genetic tests available on the market, genetic testing spending is projected to increase from $13B in 2020 to $29B by 2026. The growth and complexity of these tests create clinical and payment appropriateness challenges. …

Case Study: Genetic Test Payment Integrity Read More »

Solverwp- WordPress Theme and Plugin